Push-Button Microfluidic Platform with Dual-Signal Nanoprobes for Enhanced Sensitivity Detection of Healthcare-Associated Infection Pathogens at Point-of-Care
Analytical Chemistry · 24.02.2026 · 98 (7) · 5214-5226
DOI: 10.1021/acs.analchem.5c05437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 09.02.2026. Verfasst von Liping Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Physical Science and Information Technology, Anhui University, Hefei 230601, China. Hauptthemen laut MEDLINE: Point-of-Care Systems, Staphylococcus aureus, Cross Infection, Microfluidic Analytical Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Themen: Nosokomiale Infektionen
Abstract (Originalsprache)
Healthcare-associated infection (HAI) pathogens cause severe nosocomial outbreaks, jeopardizing patient safety and straining healthcare systems. Conventional loop-mediated isothermal amplification–lateral flow immunoassay (LAMP-ICA) allows rapid pathogen detection but is constrained by low sensitivity, a high false-positive rate, and an extended detection time. To address these limitations, we present a dual-mode (colorimetric/fluorescent) microfluidic biosensing platform based on silicon–gold/quantum dot core–shell nanoprobes (Si@Au/DQD NPs). The platform incorporates two key innovations: (1) The colorimetric/fluorescent dual-signal Si@Au/DQD nanoprobe enhances detection reliability and sensitivity through dual-signal complementary verification and multilayered QD design, halving the LAMP amplification time compared to traditional colloidal gold systems, and (2) a modular microfluidic chip integrates LAMP amplification and ICA detection within a closed system, effectively preventing leakage and contamination of amplification products. Performance evaluation showed that the fluorescence detection limit of this system for Staphylococcus aureus ( S. aureus ), Legionella pneumophila ( L. pneumophila ), and Klebsiella pneumoniae ( K. pneumoniae ) reaches 82–140 CFU/mL, with the entire process completed within 30 min. In addition, the detection of 25 clinical environmental samples verifies the practicality of the designed integrated detection platform. With high sensitivity, strong specificity, and dual-mode capability for qualitative colorimetric screening and quantitative fluorescence analysis, this technology offers an efficient solution for point-of-care testing (POCT) of HAI pathogens, particularly in resource-limited settings and in on-site emergency diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institutes of Physical Science and Information Technology, Anhui University, Hefei 230601, China.
- Hefei Institute of Physical Science, Chinese Academy of Sciences, Hefei 230031, PR China.
- Department of Nosocomial Infection Control, Anhui No.2 Provincial People's Hospital, Hefei, Anhui 230041, China.
ORCID-Profile: Shuai Zheng, Shu Wang
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Dai, L., Wang, Y., Wu, X., Wang, Q., Li, Z., Liu, Y., Zhang, L., Zheng, S., & Wang, S. (2026). Push-Button Microfluidic Platform with Dual-Signal Nanoprobes for Enhanced Sensitivity Detection of Healthcare-Associated Infection Pathogens at Point-of-Care. Analytical Chemistry, 98(7), 5214-5226. https://doi.org/10.1021/acs.analchem.5c05437
Vancouver
Dai L, Wang Y, Wu X, Wang Q, Li Z, Liu Y, et al. Push-Button Microfluidic Platform with Dual-Signal Nanoprobes for Enhanced Sensitivity Detection of Healthcare-Associated Infection Pathogens at Point-of-Care. Analytical Chemistry. 2026;98(7):5214-5226. doi:10.1021/acs.analchem.5c05437
BibTeX
@article{Dai2026,
author = {Dai, Liping and Wang, Yun and Wu, Xiaosong and Wang, Qian and Li, Zhigang and Liu, Yong and Zhang, Long and Zheng, Shuai and Wang, Shu},
title = {Push-Button Microfluidic Platform with Dual-Signal Nanoprobes for Enhanced Sensitivity Detection of Healthcare-Associated Infection Pathogens at Point-of-Care},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {7},
pages = {5214--5226},
doi = {10.1021/acs.analchem.5c05437}
}
EUVIMED